The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Thomas S. Otis sits on this spectrum.
This scientist: 85 publications — 10th percentile
10% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas S. Otis sits on this spectrum.
This scientist: 49 D-Index — 39th percentile
39% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Thomas S. Otis is affiliated with University College London in the United Kingdom. Their research spans several fields, including Biochemistry, Genetics and Molecular Biology, as well as Medicine. The subfields of study especially relevant to their work include Genetics, Molecular Biology, and Cardiology and Cardiovascular Medicine.
The scientist's research primarily focuses on virus-based gene therapy, CRISPR and genetic engineering, and viral infections and immunology. These topics appear consistently across their publications, highlighting a concentration on advanced molecular techniques and immunological responses related to viruses and genetic therapeutics.
Otis has contributed to research published in the Annual Review of Neuroscience, among other venues. Their recent paper is titled "Adeno-Associated Virus Toolkit to Target Diverse Brain Cells," published in 2022 in the Annual Review of Neuroscience.
Frequent co-authors accompanying Otis in their work include Rosemary C. Challis, Sripriya Ravindra Kumar, Xinhong Chen, David Goertsen, and Gerard Michael Coughlin.
Otis's interdisciplinary research integrates areas of molecular biology and genetics with clinical insights from cardiology and immunology, reflecting in the diversity of topics and subfields studied. Their work contributes to understanding viral mechanisms and the development of gene therapy technologies targeting brain cells and other molecular pathways.
I. Mody;Y. De Koninck;T.S. Otis;I. Soltesz
Dhruv Sareen;Jacqueline G. O’Rourke;Pratap Meera;A. K. M. G. Muhammad
Eberhard H. Buhl;Thomas S. Otis;Istvan Mody
K. J. Staley;T. S. Otis;I. Mody
H Jacob Hanchar;Paul D Dodson;Richard W Olsen;Thomas S Otis
Daniel R. Scoles;Pratap Meera;Matthew D. Schneider;Sharan Paul
Stephan J. Sanders;Arthur J. Campbell;Jeffrey R. Cottrell;Rikke S. Moller
T.S. Otis;I. Mody
Christoph Lutz;Thomas S Otis;Thomas S Otis;Vincent DeSars;Serge Charpak
Doris L Fortin;Matthew R Banghart;Timothy W Dunn;Katharine Borges
T S Otis;Y De Koninck;I Mody
T S Otis;Y De Koninck;I Mody
Thomas S. Otis;Yuh Cherng Wu;Laurence O. Trussell
Gabor Brasnjo;Thomas S. Otis
Thomas Otis;Su Zhang;Laurence O. Trussell
Thomas S. Otis;Craig E. Jahr
Thomas S. Otis;Kevin J. Staley;Istvan Mody
Thomas S. Otis;Michael P. Kavanaugh;Craig E. Jahr
T. S. Otis;I. Mody
Stephen T. Hansen;Pratap Meera;Thomas S. Otis;Stefan M. Pulst
Thomas S. Otis;Michael P. Kavanaugh
Pratap Meera;Martin Wallner;Thomas S. Otis
Vijayalakshmi Santhakumar;Martin Wallner;Thomas S. Otis
If you think any of the details on this page are incorrect, let us know.
Edith Cowan University
University of Adelaide
University of Córdoba
Korea University
University of California, Los Angeles
Boston University
University of Minnesota
Max Planck Society
University of Copenhagen
University of Liverpool
National Institute of Water and Atmospheric Research
Florida International University
Chubu University
University of California, Irvine
Duke University
University of Virginia
